Greenwich LifeSciences's total assets for Q3 2025 were $3.81M, an increase of 21.82% from the previous quarter. GLSI total liabilities were $1.62M for the fiscal quarter, a -3.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.